She researches the translation of immunotherapeutic approaches to treat high-risk hematologic malignancies in children, adolescents and young adults.

As an undergraduate, she shadowed a pediatric hematologist-oncologist and developed an interest in understanding the complexity of how haematopoiesis is disrupted by leukemia.

In 2012, Shah earned a Masters of Health Science in Clinical Research through the joint NIH-Duke University School of Medicine.

[3] Shah is a physician-scientist who serves as the head of the hematologic malignancies section of the Pediatric Oncology Branch.

Her primary research interests focus on translation of immunotherapeutic approaches to treat high-risk hematologic malignancies in children, adolescents and young adults.

[3] Her clinical work has included implementation of conduct of several Phase I trials for the treatment of relapsed/refractory pediatric acute lymphoblastic leukemia.